ABSTRACT

INTRODUCTION Sarcomas of the head and neck (HN) are rare tumors of connective tissue origin that comprise less than 1% of head and neck malignancies. They arise in any soft tissue or osseous tissues of the region and may be found in patients of any age or gender. Unfortunately, HN sarcomas do not traditionally exhibit the high local control rates seen in similar histologies elsewhere and this may be the reason for their poorer survival. This has been attributed to the traditional inability to deliver intensive treatments because of their location among the critical anatomy of the head and neck.